Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Edoardo Pucci

Showing results (11-20 of 17) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 17 results.
Italian Heart Journal : Official Journal of the Italian Federation of Cardiology|August 24, 2004
Primary coronary angioplasty in ST-elevation myocardial infarction: prediction of the thirty-day mortality risk in an unselected population of patientsAntonio Parma, Rosario Fiorilli, Marco Stefano Nazzaro, et al.
International Journal of Cardiology|February 1, 2008
Clinical outcome of patients with chronic total occlusion treated with drug-eluting stentsFrancesco De Felice, Rosario Fiorilli, Antonio Parma, et al.
International Journal of Cardiology|January 31, 2009
Long-term outcome of transcatheter patent foramen ovale closure in patients with paradoxical embolismAlberta Cifarelli, Carmine Musto, Antonio Parma, et al.
Journal of the American College of Cardiology|May 15, 2007
Randomized trial of Sirolimus-Eluting Stent Versus Bare-Metal Stent in Acute Myocardial Infarction (SESAMI)Maurizio Menichelli, Antonio Parma, Edoardo Pucci, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|May 15, 2014
One-year follow-up of patients treated with new-generation polymer-based 38 mm everolimus-eluting stent: the P38 studyGregory A Sgueglia, Flavia Belloni, Francesco Summaria, et al.
Journal of the American College of Cardiology|September 20, 2014
Second-generation drug-eluting stent implantation followed by 6- versus 12-month dual antiplatelet therapy: the SECURITY randomized clinical trialAntonio Colombo, Alaide Chieffo, Arian Frasheri, et al.
International Journal of Cardiology|January 25, 2016
Optimal duration of dual antiplatelet therapy after second-generation drug-eluting stent implantation in patients with diabetes: The SECURITY (Second-Generation Drug-Eluting Stent Implantation Followed By Six- Versus Twelve-Month Dual Antiplatelet Therapy)-diabetes substudyGiuseppe Tarantini, Luca Nai Fovino, Paola Tellaroli, et al.
Pageof 2

Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
Italian Heart Journal : Official Journal of the Italian Federation of Cardiology|August 24, 2004
Primary coronary angioplasty in ST-elevation myocardial infarction: prediction of the thirty-day mortality risk in an unselected population of patientsAntonio Parma, Rosario Fiorilli, Marco Stefano Nazzaro, et al.
International Journal of Cardiology|February 1, 2008
Clinical outcome of patients with chronic total occlusion treated with drug-eluting stentsFrancesco De Felice, Rosario Fiorilli, Antonio Parma, et al.
International Journal of Cardiology|January 31, 2009
Long-term outcome of transcatheter patent foramen ovale closure in patients with paradoxical embolismAlberta Cifarelli, Carmine Musto, Antonio Parma, et al.
Journal of the American College of Cardiology|May 15, 2007
Randomized trial of Sirolimus-Eluting Stent Versus Bare-Metal Stent in Acute Myocardial Infarction (SESAMI)Maurizio Menichelli, Antonio Parma, Edoardo Pucci, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|May 15, 2014
One-year follow-up of patients treated with new-generation polymer-based 38 mm everolimus-eluting stent: the P38 studyGregory A Sgueglia, Flavia Belloni, Francesco Summaria, et al.
Journal of the American College of Cardiology|September 20, 2014
Second-generation drug-eluting stent implantation followed by 6- versus 12-month dual antiplatelet therapy: the SECURITY randomized clinical trialAntonio Colombo, Alaide Chieffo, Arian Frasheri, et al.
International Journal of Cardiology|January 25, 2016
Optimal duration of dual antiplatelet therapy after second-generation drug-eluting stent implantation in patients with diabetes: The SECURITY (Second-Generation Drug-Eluting Stent Implantation Followed By Six- Versus Twelve-Month Dual Antiplatelet Therapy)-diabetes substudyGiuseppe Tarantini, Luca Nai Fovino, Paola Tellaroli, et al.
Pageof 2